本文へ移動
cccskills
無料GitHub で公開

endo-assess-cgm-alarms-settings

Assesses that CGM low- and high-glucose alarm thresholds are individualized to optimize patient benefit and minimize alarm fatigue. Triggered by clinician prompts to 'Review low-glucose alarm thresholds' or 'Ensure alarms are individualized and not excessive'.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.1 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Assess CGM alarm settings

STEP 1 — Gather Information

Collect recent CGM metrics (time <70 mg/dL, >180 mg/dL), current low/high alarm thresholds, frequency of alarm notifications, hypoglycemia unawareness, severe hypoglycemia history, and patient-reported alarm fatigue. → If data missing, obtain CGM download; otherwise proceed.

STEP 2 — Rule In / Rule Out

Is the patient experiencing hypoglycemia unawareness, recent severe hypoglycemia, or frequent low-glucose alarms disrupting sleep/activities? If yes, prioritize low alarm evaluation; if no, proceed to evaluate high alarm settings.

STEP 3 — Classify or Stratify

Classify alarm adequacy: low alarm too low (<60 mg/dL) causing fatigue, too high (>80 mg/dL) risking missed hypoglycemia; high alarm too low (<140 mg/dL) causing excessive alerts, too high (>250 mg/dL) missing hyperglycemia; or appropriately set.

STEP 4 — Decide

Adjust low alarm to 70–80 mg/dL if hypoglycemia unawareness or frequent low alerts; set high alarm 180–250 mg/dL or disable if consistently high without benefit; provide education on alarm response and SMBG confirmation.

Clinical Guardrails / Mimics / Pitfalls

Do not set low alarms above 80 mg/dL in hypoglycemia-unaware patients; avoid high alarms below 140 mg/dL causing alert fatigue; never replace symptomatic hypoglycemia verification with CGM alarms alone.

Concrete Clinical Example

A 45‑year‑old with T1D and hypoglycemia unawareness reports 4 nightly low alerts. Review shows low alarm at 55 mg/dL, high at 200 mg/dL. Low alarm raised to 70 mg/dL, high kept at 200 mg/dL; alerts drop to 1/night, sleep improves, no missed hypoglycemia.

Source: Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults, Endocrine Society, 2016, DOI:10.1210/jc.2016-2534

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する